Journal
Journal of Clinical Oncology
Publication Date
5-1-2024
Volume
42
Issue
13
First Page
1542
Last Page
1552
Document Type
Open Access Publication
DOI
10.1200/JCO.23.01134
Rights and Permissions
Arrillaga-Romany I, Gardner SL, Odia Y, Aguilera D, Allen JE, Batchelor T, Butowski N, Chen C, Cloughesy T, Cluster A, de Groot J, Dixit KS, Graber JJ, Haggiagi AM, Harrison RA, Kheradpour A, Kilburn LB, Kurz SC, Lu G, MacDonald TJ, Mehta M, Melemed AS, Nghiemphu PL, Ramage SC, Shonka N, Sumrall A, Tarapore RS, Taylor L, Umemura Y, Wen PY. ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma. J Clin Oncol. 2024 May 1;42(13):1542-1552. doi: 10.1200/JCO.23.01134. © 2024 by American Society of Clinical Oncology. Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/
Recommended Citation
Arrillaga-Romany, Isabel; Cluster, Andrew; and et al., "ONC201 (dordaviprone) in recurrent H3 K27M-mutant diffuse midline glioma." Journal of Clinical Oncology. 42, 13. 1542 - 1552. (2024).
https://digitalcommons.wustl.edu/oa_4/4058
